KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbCellera Biologics (ABCL) Other Non-Current Assets (2020 - 2025)

Historic Other Non-Current Assets for AbCellera Biologics (ABCL) over the last 6 years, with Q3 2025 value amounting to $53.1 million.

  • AbCellera Biologics' Other Non-Current Assets fell 6046.19% to $53.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $53.1 million, marking a year-over-year decrease of 6046.19%. This contributed to the annual value of $96.5 million for FY2024, which is 243.41% up from last year.
  • AbCellera Biologics' Other Non-Current Assets amounted to $53.1 million in Q3 2025, which was down 6046.19% from $57.5 million recorded in Q2 2025.
  • AbCellera Biologics' Other Non-Current Assets' 5-year high stood at $134.2 million during Q3 2024, with a 5-year trough of $9.5 million in Q1 2021.
  • Moreover, its 5-year median value for Other Non-Current Assets was $57.5 million (2025), whereas its average is $66.8 million.
  • As far as peak fluctuations go, AbCellera Biologics' Other Non-Current Assets soared by 35443.02% in 2022, and later plummeted by 6046.19% in 2025.
  • Quarter analysis of 5 years shows AbCellera Biologics' Other Non-Current Assets stood at $30.6 million in 2021, then skyrocketed by 51.2% to $46.3 million in 2022, then soared by 103.41% to $94.2 million in 2023, then rose by 2.43% to $96.5 million in 2024, then crashed by 45.03% to $53.1 million in 2025.
  • Its Other Non-Current Assets stands at $53.1 million for Q3 2025, versus $57.5 million for Q2 2025 and $61.6 million for Q1 2025.